Local recurrence after radical nephrectomy for kidney cancer: Management and prediction of outcomes. A multi-institutional study - Abstract

BACKGROUND: Local recurrence (LR) after radical nephrectomy (RN) for kidney cancer is uncommon.

Our objectives were to analyse characteristics and therapeutic options of LR after RN and to identify survival prognostic factors.

MATERIALS AND METHODS: From a multi-institutional retrospective database, we identified 72 patients who experienced LR after RN.

RESULTS: Mean time to LR was 26.5 ± 3.3 months. The location of the recurrence was renal fossa, regional lymph node, homolateral adrenal and both renal fossa and regional lymph node for 43 (59.7%), 27 (37.5%), 9 (12.5%) and 7 (9.7%) patients, respectively. Patients were treated by surgery, systemic therapies, combination of therapies and palliative treatment in 24 (33.3%), 18 (25%), 24 (33.3%) and 6 (8.4%) cases, respectively. Within a mean follow-up of 26.4 ± 3.3 months from the date of local recurrence, 12 (16.6%) patients were alive without disease, 30 (41.7%) patients were alive with disease, 30 patients (41.6%) died including 28 (38.8%) from the disease. In multivariate analysis, time to recurrence < 1 year (P < 0.001; HR: 4.81) and surgical treatment (P = 0.027; HR: 0.33) were predictive factors.

CONCLUSIONS: Local recurrence after radical nephrectomy is associated with poor prognosis. The time to recurrence and the completeness of the surgical treatment are major prognostic factors.

Written by:
Paparel P, Bigot P, Matillon X, Bensalah K, Salomon L, Baumert H, Bastide C, Thuret R, Karsenty G, Long JA, Ammi M, Bessede T, Bin S, Roux A, Escudier B, Rioux Leclercq N, Pignot G, Soulie M, Patard JJ.   Are you the author?
Cancerology Committee of the French Association of Urology (CCAFU), Paris, France; Department of Urology, Lyon Sud University Hospital, Claude Bernard University Lyon 1, Lyon, France.

Reference: J Surg Oncol. 2013 Oct 30. Epub ahead of print.
doi: 10.1002/jso.23473


PubMed Abstract
PMID: 24174430

UroToday.com Renal Cancer Section